On October 3rd, 2024, the PREVENTABLE project held its highly anticipated Midterm Conference and PrevenTalk 2 in Rouen, France. Co-organized by SPI alongside EHMA, CHU Rouen, and Centre Henri-Becquerel, the two-day hybrid event brought together researchers, clinicians, policymakers, and stakeholders to discuss the latest findings and future strategies for managing Rare Tumour Risk Syndromes (RTRS).

The Midterm Conference served as a key milestone, with participants reviewing project progress, addressing ongoing challenges, and setting a course for the second half of the project. Expert keynote speakers and panelists delivered in-depth insights into hereditary cancer syndromes, cost-effectiveness of prevention strategies, and communication in healthcare, sparking lively discussions and collaborative problem-solving.

PrevenTalk 2 delved into the Strengths, Weaknesses, Opportunities, and Threats (SWOT) analysis of care pathways for RTRS, building on data collected from interviews with top clinicians across Europe. Moderated by EHMA, this session highlighted the need for multidisciplinary approaches and personalized care teams in RTRS management. Stakeholders discussed how to enhance patient care, with an emphasis on prevention and policy recommendations for improved outcomes. In case you missed the event, learn more HERE

The conference concluded with a reception at the Rouen Art Museum, fostering further networking and collaboration. The PREVENTABLE project is on track to continue making impactful strides in the understanding and management of RTRS, paving the way for better patient care across Europe.